# Endotis Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/endotis-pharma

- Industry: Biotechnology
- Headquarters: Paris, France
- Website: www.endotis.com
- Total disclosed funding: $41M
- Latest round: Series B (Jan 23, 2008)
- Investors on record: 4

## About

Endotis Pharma is a Paris-based company specializing in innovative pharmaceuticals. The firm focuses on developing advanced treatments for various health conditions, aiming to enhance therapeutic options.Endotis Pharma operates in the pharmaceutical sector, focusing on therapeutic innovations. The company was established in Paris, France. In January 2008, Endotis Pharma raised EUR 25 million in Series B financing, led by Wellcome Trust with participation from Endeavour Vision, Daiwa Corporate Investment, and Sofinnova Partners. This funding round brought the total amount raised to EUR 25 million, marking a significant milestone in the company's financial journey.Endotis Pharma engages in the development of pharmaceuticals, with a focus on advanced treatment solutions for various medical conditions. The company is dedicated to conducting research that leads to the creation of effective therapies capable of addressing unmet medical needs.Endotis Pharma's revenue model is centered around the successful development and commercialization of its pharmaceutical products. The firm generates income through its proprietary medications once they are approved and brought to market, although specific revenue figures are not disclosed.The future growth strategy for Endotis Pharma involves plans to enhance its product pipeline with new pharmaceutical offerings aimed at addressing specific health challenges. Following the recent Series B financing in January 2008, the company aims to utilize the EUR 25 million raised to support research and development initiatives, expand its clinical trials, and potentially enter new markets across Europe and North America by 2010.

## Funding rounds

- Series B, Jan 23, 2008, $37M — Sofinnova Partners, Wellcome Trust, Daiwa Corporate Investment, Endeavour Vision
- Series A, Jun 20, 2005, $4.8M — Sofinnova Partners

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A, Series B
- Wellcome Trust — Series B
- Daiwa Corporate Investment (https://capitalatlas.ai/funds/daiwa-corporate-investment) — Series B
- Endeavour Vision (https://capitalatlas.ai/funds/endeavour-vision) — Series B